Clinical Trial Update: Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial assessed liposomal amphotericin B for treating American cutaneous leishmaniasis in elderly patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• American Cutaneous Leishmaniasis

Drugs mentioned

• Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Cutaneous Leishmaniasis, American | Phase 1, Phase 2 | Status: COMPLETED